Clephedrone
| 4-CMC | |
|---|---|
| Molecular structure via molpic based on CDK |
| Rotamer [] | |
|---|---|
| Conformer structure via 3Dmol.js |
| Physical properties [] | |
|---|---|
| Molecular mass | 197.66 g/mol [1] |
| Predicted LogP | 2.2 [1] |
| Structural Identifiers [] | |
|---|---|
| Molecular formula | C10H12ClNO [1] |
| IUPAC name | 1-(4-chlorophenyl)-2-(methylamino)propan-1-one [1] |
| SMILES | CC(C(=O)C1=CC=C(C=C1)Cl)NC [1] |
| InChI | InChI=1S/C10H12ClNO/c1-7(12-2)10(13)8-3-5-9(11)6-4-8/h3-7,12H,1-2H3 [1] |
| InChIKey | UEJBEYOXRNGPEI-UHFFFAOYSA-N [1] |
Clephedrone (also known as Clephedrone, 4-cmc, 4-Chloromethcathinone, Dtxsid201014163, Dtxcid501436704, Unii-ptayyyzmmt, 1-(4-Chlorophenyl)-2-(methylamino)propan-1-one, para-Chloro-N-methyl-cathinone, 4-Chloromethcathinone hydrochloride or Chloromethcathinone) is a stimulant substance of the cathinone class.
Chemistry
Stereochemistry []
Clephedrone is a racemic mixture of the enantiomers.
| Stereoisomerism |
|---|
| Stereoisomer enumberation with rdkit |
Subjective effects []
Legal status []
- Brazil: Clephedrone is a F2 substance.
- Germany: Clephedrone is a Anlage I substance.
- United Kingdom: Clephedrone is a Class B substance.
- United Nations: Clephedrone is a Schedule II drug under the "Convention on Psychotropic Substances 1971".
See also []
External links []
References []
National Center for Biotechnology Information. PubChem Compound Summary for CID 82100418, Clephedrone. Accessed May 4, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/82100418
U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Clephedrone. UNII: PTAYYYZMMT. Global Substance Registration System. Accessed May 4, 2026. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/PTAYYYZMMT